Table 3. Characteristics of studies included for diagnostic meta-analysis.
| Author (year) | Country | Ethnicity | Period | No. of sample (Case/Control) | Cancer subtypes | Sample source | Method |
|---|---|---|---|---|---|---|---|
| Nam (2008) [18] | Korea | Asian | NA | 20/8 | 20 serous ovarian carcinomas. | Tissue | qRT-PCR |
| Kan (2012)a [30] | Australia | Caucasian | NA | 28/28 | 28 serous epithelial ovarian cancer. | Serum | qRT-PCR |
| Kan (2012)b [30] | Australia | Caucasian | NA | 28/28 | 28 serous epithelial ovarian cancer. | Serum | qRT-PCR |
| Zuberi (2015) [31] | India | Asian | 2012/1-2014/10 | 52/18 | 36 mucinous, 17 serous, 8 papillary, 1 clear cell, 2 endometroid, 2 undifferentiated, 1 mixed epithelial ovarian cancer. | Serum | qRT-PCR |
| Ibrahim (2015) [29] | Malaysia | Asian | 2006-2013 | 22/22 | 22 serous epithelial ovarian cancer. | Tissue | qRT-PCR |
a
Immortalized human ovarian surface epithelial cells were used as control.
b
Benign tumors were used as control.
FFPE, formalin-fixed paraffin-embedded; FC, fold change; NA, not available.